Your Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…
Happy Anniversary to Us!
I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and…
Hybrid Work Strategies: 3 Tips to Transform Engagement
In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation,…
Medical Affairs: An Orchestra, Not a Horse Race
Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had…
What’s the Latest?
There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of…
Gen Z Advice for Seasoned Boomers
“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain…